A cardiologist shared 4 seemingly healthy habits that can lead to heart failure, from too much protein to overdoing workouts
When done in excess, some habits can lead to cardiovascular issues, like heart disease.
A cardiologist warns against eating too much protein and heavy drinking on weekends.
When it comes to heart health, a lot of advice is straightforward: Eat a balanced diet, exercise regularly, and avoid vaping.
But sometimes, even the healthiest-seeming lifestyle choices can backfire, especially if done in excess. "Any extreme is likely not good for you," Dr. Dmitry Yaranov, a heart transplant cardiologist at Stern Cardiovascular in Tennessee, known on social media for his tips on heart health, told Business Insider.
Yaranov, who is the director of the advanced heart failure program at Baptist Memorial Hospital in Memphis, said he sees a fair amount of younger patients in their 20s and 30s. Some come in with few risk factors, coming in for chest pain or arrhythmia concerns, only to learn that one part of their weekly routine could be leading them to future heart disease.
"You may look fit, but it doesn't mean you're healthy," Yaranov said. He shared some common habits that may appear like longevity hacks, but can contribute to heart issues later on.
Eating a restrictive high-protein diet
Overall, protein is great for your health. Eating high-protein foods can help with weight loss, muscle growth, and hormone regulation.
When it comes to the heart, research on protein is mixed. Because some forms of protein have higher cholesterol (such as red meat and dairy), eating too much of them may negatively impact heart health. In one 2018 study, men in their 40s to 60s who followed high-protein diets (and consumed mostly high-cholesterol foods) increased their risk of heart failure by 50%.
While athletes may feel motivated to fit in as much protein as possible, Yaranov said that eating way more than your daily recommended amount can overwork your kidneys, leading to inflammation. (Inflammation increases your risk of heart disease.) Plus, he said, taking ultra-processed protein supplements, such as protein powder, can also negatively impact cardiovascular health.
"I've seen bodybuilders and athletes who look great, but they lack balance" when it comes to their diets, Yaranov said. "They end up with weak hearts and blocked arteries."
He's a fan of the Blue Zones and Mediterranean diets, which feature both heart-healthy protein sources like fish and beans and anti-inflammatory foods like fruits, vegetables, and whole grains.
Only drinking on the weekends
In general, there's no safe amount of alcohol you can drink. However, the National Center for Health Promotion and Disease Prevention says that if you want to stay within healthy limits, you shouldn't exceed more than seven drinks a week (one a day) if you're a woman and 14 (two a day) if you're a man.
There's a caveat, though: you should avoid binge drinking, defined as four or more drinks per occasion for women and people over 65, and five drinks for men. Yaranov said some of the "sickest hearts" he's seen in younger patients in those who drink too much at once.
These patients "don't necessarily drink daily, but they go hard on the weekends," he said. Some might even stay sober throughout the week, working out every day and eating a balanced diet. But "this one day of heavy alcohol use, it's not going to go unnoticed."
Excessive drinking can cause a host of heart problems, from abnormal heart rhythms and heightened blood pressure to a greater risk of developing heart disease. The most common alcohol-related issue Yaranov sees is dilated cardiomyopathy, in which the heart's lower chambers become enlarged and weakened, unable to pump blood properly.
In the end, it's better to have a mid-week glass of wine than pound back shots on a Saturday night, Yaranov said.
In some cases, smoking weed
Cannabis use has risen over the years, with some people swapping weed for alcohol entirely as a more "natural" recreational drug.
Yaranov said he is concerned about a 2025 study showing that frequent marijuana use is linked to increased risks of heart attack and stroke.
He said that members of the medical community are still learning about the full effects of cannabis on heart health and what the proper guidance should be around using it.
Research on the topic is mixed and limited — some studies found cannabis use had no effect or even a positive effect on heart health. It's also difficult for researchers to isolate cannabis from other substance use, such as alcohol, drugs, or tobacco.
In the meantime, Yaranov said he sees lots of younger patients with heart issues who otherwise have no risk factors except for heavy marijuana use.
"With cannabis use as a daily habit, I think it's important for us to have this conversation now," he said. "A lot of times, this comes from this idea that it's harmless because it's an herb. I don't think that's the case."
Pushing your workouts to the extreme
Yaranov said that endurance athletes can experience "athlete's heart," a remodeling of their heart, with some heart muscles thickening to adapt to high-intensity training. While athlete's heart isn't itself dangerous, it can mask or mimic more serious heart conditions, like hypertrophic cardiomyopathy, a genetic condition that causes thickened heart walls and can lead to cardiac arrest.
He said this is very rare — you're more at risk of athlete's heart if you're a highly skilled athlete than if you just went too hard at the gym a few times. The bigger heart issues might stem more from the rise-and-grind lifestyle of working out.
If a person frequently foregoes sleep to squeeze in those 5 a.m. workouts, they're increasing inflammation in their body, which is directly tied to cardiovascular risk. Poor sleep can also elevate stress, which leads to excess cortisol production, blood pressure elevation, and greater visceral fat.
Yaranov said that healthy stress and sleep levels are harder to quantitatively measure than, say, your cholesterol. People also vary in what sleep schedules work for them or in how they channel stress.
"We know it hurts you, but we don't know how much stress is enough to hurt you," he said. As with everything else, he said that balance is always the key to great heart health.
Read the original article on Business Insider
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available
The celebration marks a major milestone for the patent-pending, next-generation, rapid, compact, and hand-held Daxor BVA™. Oak Ridge, TN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces that the official replay of its Nasdaq Closing Bell Ceremony is now available. The ceremony, which took place on August 8, 2025, commemorated the FDA 510(k) clearance for its patent-pending, next-generation, rapid, compact, hand-held, lab-based new Daxor BVA™ (Blood Volume Analyzer). You can watch the full replay of the event here: Closing Ceremony. For more information, visit Sign up to receive news on Daxor's innovative technology HERE. About Daxor Corporation Daxor Corporation (NASDAQ: DXR) is tackling healthcare's "multi-billion-dollar silent crisis", the inability to precisely measure blood volume. This often results in suboptimal care, prolonged hospital stays, and increased readmissions for many high-cost medical conditions like heart failure and those requiring ICU care. With 50 years of experience and innovation, Daxor's patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. This empowers clinicians to make individualized treatment decisions that significantly improve patient outcomes and deliver substantial efficiencies in value-based healthcare. Daxor is ISO certified and operates a U.S.-based, 20,000-square-foot state-of-the-art manufacturing facility, positioning the company for accelerated market expansion. Forward-Looking Statements Certain statements in this release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, statements regarding the impact of hiring sales staff and expansion of our distribution channels. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risk associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and additional other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations Contact:Investor Relations Contact:Bret ShapiroCOO – Head of Capital MarketsCOREIR(561)-479-8566-Cellbrets@ in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
Here's Why Halozyme Therapeutics (HALO) Traded Town in Q2
Meridian Funds, managed by ArrowMark Partners, released its 'Meridian Growth Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets made a significant rebound during the quarter, increasing 23% from intra-period lows to close at record highs. Against this backdrop, the fund returned 4.10% (net) compared to the Russell 2500 Growth Index's 11.31% return. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Meridian Growth Fund highlighted stocks such as Halozyme Therapeutics, Inc. (NASDAQ:HALO). Based in San Diego, California, Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company. The one-month return of Halozyme Therapeutics, Inc. (NASDAQ:HALO) was 11.11%, and its shares gained 12.32% of their value over the last 52 weeks. On August 11, 2025, Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock closed at $62.89 per share, with a market capitalization of $7.356 billion. Meridian Growth Fund stated the following regarding Halozyme Therapeutics, Inc. (NASDAQ:HALO) in its second quarter 2025 investor letter: "Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a leading drug delivery platform company built around its proprietary and commercially validated ENHANZE® technology. This innovative enzyme enables the subcutaneous delivery of biologics and fluids, transforming hours-long intravenous (IV) infusions into quick injections that can be delivered in just minutes. By doing so, ENHANZE can significantly reduce the treatment burden for patients and ease capacity constraints for healthcare providers. Shares of Halozyme declined during the period following news that the Centers for Medicare & Medicaid Services (CMS) may reconsider how it classifies reformulated drugs using ENHANZE. Under the proposed change, such formulations may no longer qualify as 'new drugs,' potentially subjecting them to Medicare price negotiations earlier than previously expected. While the proposal remains under review, we believe ENHANZE continues to offer meaningful advantages—including fewer injection-site reactions and substantial time and cost savings for clinics—making it an important innovation in drug delivery. We slightly reduced our position in the company during the quarter." An image of a research technician wearing lab coat with a syringe full of biopharmaceuticals. Halozyme Therapeutics, Inc. (NASDAQ:HALO) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 31 hedge fund portfolios held Halozyme Therapeutics, Inc. (NASDAQ:HALO) at the end of the first quarter, which was 25 in the previous quarter. In the second quarter of 2025, Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported revenue of $326 million, representing 41% year-over-year increase. While we acknowledge the potential of Halozyme Therapeutics, Inc. (NASDAQ:HALO) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Halozyme Therapeutics, Inc. (NASDAQ:HALO) and shared the list of most undervalued biotech stocks to buy. Halozyme Therapeutics, Inc. (NASDAQ:HALO) rose in the previous quarter due to strong earnings and its decision to focus on its core business. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Mario and Courtney Lopez Team Up with NaturVet to Spotlight Award-Winning Pet Supplements at SuperZoo 2025
The duo will showcase NaturVet's offerings, led by All-In-One Daily Care, recently named "Dog Vitamin/Supplement Innovation of the Year" LAS VEGAS, Aug. 12, 2025 /PRNewswire/ -- Mario and Courtney Lopez are joining NaturVet at SuperZoo 2025 to celebrate the brand's refreshed look and inspire pet parents to take a proactive approach to their pets' health and wellness. The show is August 13-15 at Mandalay Bay Convention Center, and the beloved television personalities will appear at booth #9747 on day two for a media/VIP event. "Having Mario and Courtney Lopez join us at SuperZoo is incredibly exciting," said Geoff Granger, CEO at NaturVet. "We share a passion for helping pets live healthier, happier lives, and their involvement allows us to extend this message to even more pet parents." NaturVet's All-In-One Daily Care line was recently named "Dog Vitamin/Supplement Innovation of the Year" by the 2025 Pet Innovation Awards, a prestigious program that recognizes the most innovative companies, services and products in the global pet industry. With comprehensive, vet-formulated benefits and easy-to-give soft chews, the All-In-One line stood out for delivering real results for dogs at every life stage, from puppyhood through their senior years. NaturVet will showcase its award-winning All-In-One Daily Care line at SuperZoo, along with a range of new product innovations including: All-In-One Puppy Daily Care: A soft chew supplement with a hickory smoked bacon flavor designed to support the needs of growing puppies with six essential key benefits, including skeletal support, brain development, healthy digestion and immune health. Formulated for younger dogs, it features the exclusive dental care ingredient PlaqueOff® for added oral health support. All-In-One Adult Daily Care: A 10-in-1 soft chew supplement designed to support adult dogs with targeted benefits, including joint health, digestion, immunity, skin and coat health and more. Featuring a delicious hickory smoked bacon flavor and the exclusive dental care ingredient PlaqueOff®, it helps support overall health and well-being throughout adulthood. All-In-One Senior Daily Care: An 8-in-1 soft chew supplement designed to support aging dogs by targeting areas such as joint health, mobility and gut health, while also providing brain, heart and vision support. It features the exclusive ingredient PlaqueOff® for dental care and tailored ingredients that help support longevity and immunity. With its hickory smoked bacon flavor, the soft chews are easy to give to senior dogs. Lickable Supplements for Cats: A pump-dispensed supplement designed for easy dosing. Available in Hip & Joint, Calming and Multi-Vitamin formulas, it provides essential support in a mess-free format, making supplementation effortless for cat owners. Lickable Supplements for Dogs: A peanut butter-flavored supplement for dogs, available in Hip & Joint, Calming and Multi-Vitamin formulas. Designed for easy dosing with a pump, it offers a convenient, mess-free alternative to traditional supplements while addressing key dog health and wellness needs. SuperZoo attendees are invited to stop by booth #9747 to meet the NaturVet team, explore some of their best-selling products and see how the Lopez family is partnering with NaturVet to inspire happier, healthier pets. To learn more about NaturVet and its complete line of vet-formulated supplements, visit About NaturVet NaturVet is a 30-year pioneer and present-day innovator manufacturing high-quality pet products designed to support the health, wellness and quality of life for pets and pet parents. Headquartered in Southern California, NaturVet produces dog, cat and equine supplements including all-in-one vitamins and targeted solutions for calming, digestion, allergy aids, skin and joint support. Formulated by veterinarians and manufactured in-house to ensure quality, NaturVet's products are made with ingredients which are sourced from trusted global suppliers and tested to meet rigorous standards by the National Animal Supplement Council (NASC). For more information, visit View original content to download multimedia: SOURCE NaturVet Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data